NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Skin2Neuron

Skin2Neuron

Private
SydneyHealthcare & Life Scienceshttps://www.s2n.bio/

Last Round

Grant

Sep 22, 2025

Total Funding Raised

$2.87M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Skin2Neuron is a regenerative medicine company developing a first-in-class autologous neurorestorative cell therapy derived from human hair follicles to treat neurodegenerative diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Application

Keywords

cell therapyregenerative medicineautologous cell therapyneurodegenerative diseaseAlzheimer's diseaseneuron regenerationhair follicle stem cellsneuroprecursor cellsneuronal culturesdisease modelingdisease in a dishdrug discoverynon-genetic modificationpreclinical researchParkinson's diseasetoxicity testingCDMO

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Skin2Neuron Comparables

Compare Skin2Neuron with similar companies based on industry and business-model similarity.

Skin2Neuron comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BrainXell Therapeutics
80%
Regeneration Biomedical, Inc.
79%
Aspen Neuroscience
70%

Skin2Neuron Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 22, 2025
VC RoundOct 1, 2024
GrantMay 1, 2024

Key People

Founding team and executive leadership

Michael Valenzuela

Founder and Chief Scientific Officer

Founding Team

Skin2Neuron Investors

Notable investors and investment history

Skin2Neuron investors
InvestorRounds
CUREatorGrant
ArtesianVC Round
SYNthesis BioVenturesVC Round
Karst Peak RxVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 22, 2025

    $1.55M grant round led by CUREator

  • Aug 25, 2025

    Grew 30% QoQ, from 10 to 13 employees.

Skin2Neuron Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Skin2Neuron Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Skin2Neuron's valuation, stock price, and market status.

Firmographic Details

HeadquartersSydney
Employee Range12
Year Founded2019
Last FundingSep 22, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.